Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An update from OrganiGram Holdings ( (TSE:OGI) ) is now available.
Organigram Global Inc. announced it will release its third quarter fiscal 2025 earnings results on August 13, 2025. The company will host a conference call to discuss these results, reflecting its continued focus on market leadership and expansion in the cannabis industry. This announcement underscores Organigram’s commitment to transparency and stakeholder engagement, potentially impacting its market positioning and investor relations.
The most recent analyst rating on (TSE:OGI) stock is a Buy with a C$3.00 price target. To see the full list of analyst forecasts on OrganiGram Holdings stock, see the TSE:OGI Stock Forecast page.
Spark’s Take on TSE:OGI Stock
According to Spark, TipRanks’ AI Analyst, TSE:OGI is a Neutral.
OrganiGram Holdings’ stock is bolstered by robust earnings call guidance and strategic corporate events, highlighting its growth potential. However, concerns over profitability and cash flow, along with mixed technical indicators, temper the overall score.
To see Spark’s full report on TSE:OGI stock, click here.
More about OrganiGram Holdings
Organigram Global Inc. is a leading Canadian cannabis company listed on NASDAQ and TSX, specializing in high-quality cannabis products for adult recreational use. The company has expanded its footprint in the US and Canadian cannabinoid beverages markets through the acquisition of Collective Project Limited. Organigram operates multiple facilities across Canada, focusing on cultivation, processing, and manufacturing, and is regulated by the Cannabis Act and Cannabis Regulations in Canada.
Average Trading Volume: 102,968
Technical Sentiment Signal: Sell
Current Market Cap: C$250.4M
See more data about OGI stock on TipRanks’ Stock Analysis page.